D-745-2014 Class III Terminated
FDA drug recall D-745-2014 was initiated by Pfizer Inc. on Jan 2, 2014 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant. The recall status is terminated (terminated Mar 14, 2016). Affected quantity: 101,681 Vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2014
- Initiation Date
- Jan 2, 2014
- Termination Date
- Mar 14, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 101,681 Vials
Product description
Zithromax (azithromycin for injection), 500 mg/vial, Sterile, Rx Only, For I.V. infusion only, No latex, No preservative, Made in Ireland, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-3150-84
Reason for recall
Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot Number/Expiration Date G81845, Exp 10/03/14 0B0CJ, Exp 02/06/15 G44710, Exp 07/10/15 G65241, Exp 07/11/15 G80003, Exp 10/17/15 G82722, Exp 11/27/15 G93028, G95309, Exp: 01/23/16 G97641, Exp 01/30/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-745-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026